Bioretec Oyj
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more
Market Cap & Net Worth: Bioretec Oyj (BRETECN0125)
Bioretec Oyj (HE:BRETECN0125) has a market capitalization of $17.77K (€17.31K) as of March 19, 2026. Listed on the HE stock exchange, this Finland-based company holds position #44120 globally and #153 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bioretec Oyj's stock price €1.79 by its total outstanding shares 9669 (9.67K).
Bioretec Oyj Market Cap History: 2025 to 2025
Bioretec Oyj's market capitalization history from 2025 to 2025. Data shows growth from $17.77K to $17.77K (0.00% CAGR).
Bioretec Oyj Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bioretec Oyj's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BRETECN0125 by Market Capitalization
Companies near Bioretec Oyj in the global market cap rankings as of March 19, 2026.
Key companies related to Bioretec Oyj by market ranking:
- Eleving Group S.A. (XETRA:OT8): Ranked #44111 globally with a market cap of $16.94K USD ( €16.50K EUR).
- BBVA Sociedad Titulizadora S.A. (LIM:FIBPRIME): Ranked #44112 globally with a market cap of $16.93K USD ( S/.64.11K PEN).
- Union Korea Pharm. Co. Ltd. (KO:080720): Ranked #44121 globally with a market cap of $16.82K USD ( ₩24.63 Million KRW).
- Fauji Fertilizer Company Ltd (KAR:FFC): Ranked #44122 globally with a market cap of $16.82K USD ( PKRs4.69 Million PKR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #44111 | Eleving Group S.A. | XETRA:OT8 | $16.94K | €1.66 |
| #44112 | BBVA Sociedad Titulizadora S.A. | LIM:FIBPRIME | $16.93K | S/.6.65 |
| #44121 | Union Korea Pharm. Co. Ltd. | KO:080720 | $16.82K | ₩2725.00 |
| #44122 | Fauji Fertilizer Company Ltd | KAR:FFC | $16.82K | PKRs481.36 |
Bioretec Oyj Historical Marketcap From 2025 to 2025
Between 2025 and today, Bioretec Oyj's market cap moved from $17.77K to $ 17.77K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €17.77K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bioretec Oyj was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.77K USD |
| MoneyControl | $17.77K USD |
| MarketWatch | $17.77K USD |
| marketcap.company | $17.77K USD |
| Reuters | $17.77K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.